Victor J. Dzau, MD, Distinguished Lecture in Cardiovascular Medicine
Next Speaker
Dale Abel, MD, PhD,
William S. Adams Distinguished Professor of Medicine
Chair and Executive Director
Department of Medicine
David Geffen School of Medicine and UCLA Health
August 14–15, 2025
In-person at the Paul Berg Hall, Li Ka Shing Center and online available
More information to come
The annual Victor J. Dzau Distinguished Lecture in Cardiovascular Medicine series honors the extensive contributions of Dr. Victor Dzau to the field of cardiovascular medicine. To nominate an individual with exceptional contributions to cardiovascular medicine for this distinguished award, please complete the form above.
Questions? Please contact Francesca Tongco.
Previous Lectures
Sorting through the Cardiomyopathy Genetics
Elizabeth McNally, MD, PhD
Elizabeth Ward Professor and Director, Center for Genetic Medicine, Northwestern University, Feinberg School of Medicine
8/16/2024
Investing in Discovery Science to Promote Equity in Heart Health
Gary Gibbons, MD
Director, National Heart, Lung, Blood Institute (NHLBI) at NIH
11/30/2023
From The Heart to The Brain: Children as The Golden Age
Valentin Fuster, MD, PhD
Physician-in-Chief, Mount Sinai Hospital Director, Zena and Michael A. Weiner Cardiovascular Institute Icahn School of Medicine at Mount Sinai
11/28/2022
The War on Heart Failure
Eugene Braunwald, MD
Distinguished Hersey Professor of Medicine at Harvard Medical School
Chair Emeritus, Department of Medicine
Founding Chair of the TIMI Study Group at the Brigham and Women’s Hospital.
12/8/2021
Founder's Bio
Victor J. Dzau, MD
Victor J. Dzau, M.D. is the President of the US National Academy of Medicine (NAM), Vice Chair of the US National Research Council, and is Chancellor Emeritus and James B. Duke Distinguished Professor of Medicine at Duke University. Dr. Dzau was previously Hersey Professor of Medicine at Harvard Medical School and Chairman of Department of Medicine at Brigham and Women’s Hospital as well as Bloomfield Professor and Chairman of Department of Medicine at Stanford, as well as William Irwin Professor and Chief of the Cardiovascular Division and Director of Cardiovascular Research Center at Stanford.
He is an internationally acclaimed leader and physician scientist who has made a significant impact through his seminal research in cardiovascular medicine and genetics. His work laid the foundation for the development of the class of lifesaving drugs used globally to treat hypertension and heart. He pioneered research in vascular gene therapy and was the first to introduce DNA decoy molecules in humans in vivo.
Among his many honors and recognitions are the American Heart Association Research Achievement Award, the Max Delbruck Medal from Germany, Gustav Nylin Medal from the Swedish Royal College of Medicine, the Ellis Island Medal of Honor, the Poulzer Prize of the European Academy of Sciences and Arts, and the Henry Freisen International Prize. In 2019, he was named an Honorary Citizen of Singapore- the highest level of honor bestowed to a foreign citizen conferred by the President of Singapore. He has been elected to the National Academy of Medicine, the American Academy of Arts and Sciences, the European Academy of Sciences and Arts, UK Academy of Medical Sciences, the Japan Academy, Mexican Academy of Medicine, Chinese Academy of Engineering and Academia Sinica. He has received 16 honorary doctorates.